Ana Rodríguez, Author at Baylor College of Medicine Blog Network

There is currently a debate about whether herpes virus infections play a role in Alzheimer’s disease and Baylor College of Medicine researchers are actively contributing

From The Labs

Image of the Month: Human breast epithelial cells

February 4, 2020 alternative splicing, Breast Cancer, Human breast epithelial cells, Research

Epithelial cells line the lobules (small lobes) and terminal ducts of the breast and carry out the important function of making milk. Cancer scientists, such

From The Labs

From my perspective: Victoria Tenge shares her experience as a graduate student at Baylor

January 30, 2020 bile acids, Graduate Student, Norovirus, public speaking, Research, Virology

From the Labs interviewed Victoria Tenge to learn about her experience as a graduate student at Baylor College of Medicine. She shared her love for

From The Labs

Come on in: Bile acids open the door to norovirus infection

January 28, 2020 bile acids, endocytosis, enteroids, foodborne illness, miniguts, Norovirus, Research

Some people call it the cruise ship virus, but norovirus can be found in many other places. People can catch this very contagious virus from

From The Labs

Six is better than two: assay assesses multiple cellular pathways at once

January 23, 2020 Cancer, luciferase, multiple cellular pathways, multiplexed assay, Research

Scientists strive to have a better understanding of the complex biological processes involved in health and disease, and what they can learn usually goes hand-in-hand

From The Labs

What extensive protein analysis revealed about cancer

January 21, 2020 Cancer, cancer proteome analysis, cancer subtypes, Research, tumor microenvironment

Cancer is currently understood not as a single disease, but as a collection of diseases that can develop through alterations in different molecular pathways. This

From The Labs

Becoming metastatic: how FOXA1 triggers metastatic behavior in breast cancer

January 16, 2020 endocrine resistant breast cancer, ER positive breast cancer, FOXA1, HIF-2a, Metastatic breast cancer, Research

About 75 percent of breast cancers have estrogen receptors, hence they are called estrogen receptor positive (ER+). Original ER+ breast cancer cells depend on estrogen